Related Experiment Video
Updated: Apr 19, 2026
Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Identifying glioblastoma gene networks based on hypergeometric test analysis
Vasileios Stathias1, Chiara Pastori2, Tess Z Griffin3
1Department of Human Genetics & Genomics, University of Miami Miller School of Medicine, Miami, Florida, 33136, United States of America; Department of Psychiatry and Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, Florida, 33136, United States of America.
This study introduces a bioinformatics pipeline to find patient-specific cancer therapies by comparing individual tumor gene expression to The Cancer Genome Atlas (TCGA) database, aiding glioblastoma (GBM) research.
Area of Science:
- Oncology
- Bioinformatics
- Genomics
Background:
- Personalized cancer therapy requires identifying specific genomic and transcriptional alterations in individual tumors.
- Analyzing single tumor samples poses statistical challenges due to limitations in standard analysis techniques.
Purpose of the Study:
- To develop a bioinformatics pipeline for identifying differentially expressed genes and networks in individual tumors.
- To compare tumor-specific gene expression profiles against a large cohort database (TCGA) for identifying potential therapeutic targets.
Main Methods:
- RNA sequencing was performed on individual glioblastoma (GBM) tumor samples.
- A bioinformatics pipeline was devised to filter sequencing results through The Cancer Genome Atlas (TCGA) database.
- Hypergeometric-based analysis of gene pairs was used to identify overrepresented gene networks.
Main Results:
- The pipeline successfully identified gene networks overrepresented in GBM samples compared to controls.
- Experimental validation confirmed the identified gene networks.
- The study demonstrates a novel workflow for uncovering patient-specific genes and networks.
Conclusions:
- This approach provides a viable method for identifying patient-specific genes and networks in glioblastoma (GBM) and potentially other cancers.
- The developed bioinformatics pipeline facilitates the discovery of targeted therapies for individual cancer patients.
- Comparing individual tumor data with large public databases like TCGA is effective for identifying clinically relevant molecular signatures.
